A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors

NCT01090960 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genentech, Inc.